Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |